Systemic lupus erythematosus (SLE) is an autoimmune and multisystemic chronic
inflammatory disease that can affect various organs, including skin, joints, kidneys, lungs …

Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …

Pulmonary manifestations of systemic lupus erythematosus (SLE) are wide-ranging and
debilitating in nature. Previous studies suggest that anywhere between 20 and 90% of …

The EULAR/ACR 2019 classification criteria for SLE constitute a current and optimized
clinical approach to SLE classification. Classification is still not based on molecular …

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with multiorgan
manifestations, including pleuropulmonary involvement (20–90%). The precise mechanism …

Pulmonary Hypertension (PH) is a common manifestation in patients with Systemic Lupus
Erythematosus (SLE) and varies from asymptomatic to life-threatening disease. PH can …

Background: Recent guidelines provide better treatment and management of pregnancy in
women with systemic lupus erythematosus (SLE). In this analysis, we aimed to …

Connective tissue diseases (CTDs) include a spectrum of disorders that affect the
connective tissue of the human body; they include autoimmune disorders characterized by …

Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease
characterized by a wide spectrum of clinical manifestations. The respiratory system can be …

Background Diffuse alveolar hemorrhage (DAH) is a serious complication that can arise
from systemic lupus erythematosus (SLE) and other autoimmune diseases. While current …